Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.73%
#4 Black Phoenix Black Phoenix +334.12%
#5 aPriori aPriori +117.17%
#6 Bedrock Bedrock +70.28%
#7 Prom Prom +40.32%
#8 Cysic Cysic +39.09%
#9 COTI COTI +38.17%
#10 Playnance Playnance +34.56%
Coin of the day
Wrapped One Wrapped One
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Rang in Aktien #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Aktienkurs
$0.85
Zuletzt synchronisiert: 2025-01-21
Marktkapitalisierung
$411.40
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Fresh2 Group Limited (FRES)

Kategorie

Healthcare
Operative Marge für Fresh2 Group Limited (FRES)
Operative Marge zum August 2026 TTM: -870.20%
Laut den neuesten Finanzberichten und dem Aktienkurs von Fresh2 Group Limited beträgt die aktuelle operative Marge (TTM) -870.20%. Am Ende des Jahres 2021 lag die operative Marge bei -589.60%.
Historie der operativen Marge von Fresh2 Group Limited von 2017 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) -870.20% 0.00%
2022 -870.20% 47.59%
2021 -589.60% 29.85%
2020 -454.07% -44.95%
2019 -824.85% 91.27%
2018 -431.24% -40.34%
2017 -722.85% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -100.04%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.03%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.04%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.